KOMRILU
Glaxo Group Limited
Mark For: KOMRILU® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79280370 |
| Registration Number | 6121500 |
| Mark Literal Elements | KOMRILU |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | PUBLICATION AND ISSUE SECTION 2020-08-11 |
| Basis | 66(a) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | No |
| Filed ITU | No |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | Yes |
| Current Basis | No |
| No Basis | No |
Timeline
| 2020-01-13 | Application Filed |
| 2020-03-05 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2020-03-05 | Status: Live/Pending |
| 2020-03-10 | Transaction Date |
| 2020-05-26 | Published |
| 2020-08-11 | Location: PUBLICATION AND ISSUE SECTION |
| 2020-08-11 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
| 2020-08-11 | Trademark Registered |
| 2025-08-11 | Maintenance Early File Date |
| 2026-08-11 | Maintenance On Time Date |
| 2027-02-11 | Maintenance Late Fee Date |
Trademark Parties (Applicants & Owners)
| Party: |  Glaxo Group Limited |
| Address | 980 Great West Road Brentford Middlesex TW8 9GS UNITED KINGDOM |
| Legal Entity Type | Registered Company |
| Legal Entity State | UNITED KINGDOM |
Documents
 Application | MULTI | 2020-03-05 |
 Drawing | JPEG | 2020-03-05 |
| Filing Receipt Trademark Application | XML | 2020-03-13 |
| Offc Action Outgoing | XML | 2020-03-18 |
| XSearch Search Summary | XML | 2020-03-18 |
| IB-1rst Refusal Note | XML | 2020-03-28 |
| Response to Office Action | XML | 2020-04-07 |
| Amendment and Mail Process Complete | MULTI | 2020-04-08 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2020-04-09 |
| IB-Processed Transaction | XML | 2020-04-16 |
| Notice of Publication | XML | 2020-05-06 |
| Notification Of Notice of Publication | XML | 2020-05-06 |
| OG Publication Confirmation | XML | 2020-05-26 |
| Registration Certificate | 2020-08-11 | |
| IB-Final Disposal To | XML | 2020-11-24 |
| IB-Processed Transaction | XML | 2020-12-10 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical and medicinal preparations and substances; vaccines |
| GS0051 | Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2020-12-12 | |
| FINAL DISPOSITION PROCESSED | 2020-11-24 | 73787 |
| FINAL DISPOSITION NOTICE SENT TO IB | 2020-11-24 | |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2020-11-11 | |
| REGISTERED-PRINCIPAL REGISTER | 2020-08-11 | |
| PUBLISHED FOR OPPOSITION | 2020-05-26 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-05-26 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-05-06 | |
| REFUSAL PROCESSED BY IB | 2020-04-18 | |
| ASSIGNED TO LIE | 2020-04-17 | 68552 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-04-08 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-04-07 | 88889 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-04-07 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-04-07 | 88889 |
| REFUSAL PROCESSED BY MPU | 2020-03-28 | 76533 |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2020-03-28 | |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2020-03-19 | |
| NON-FINAL ACTION WRITTEN | 2020-03-18 | 76079 |
| ASSIGNED TO EXAMINER | 2020-03-15 | 76079 |
| APPLICATION FILING RECEIPT MAILED | 2020-03-13 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-03-09 | |
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2020-03-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 